Search results :

Famciclovir

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: J05AB09, S01AD07

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11
Upper respiratory tract infection Upper respiratory tract infection 31.8% 31.7% x x
Infection Infection 24.7% 25.4% x x
Sinusitis Sinusitis 19.5% 15.9% x x
Pharyngitis Pharyngitis 11% 14.3% x x
Headache Headache postmarketing — 5.3% - 39.3% 3.9% - 42.9% x x x x x x x x x x x
Back pain Back pain 0.602% - 12.3% 14.3% x x
Nausea Nausea postmarketing — 1.5% - 12.5% 3.2% - 11.6% x x x x x x x x x x x
Neutropenia Neutropenia 3.2% 1.5% x x x
Enzyme abnormality Enzyme abnormality 2.2% 3.2% x x x
Dyspepsia Dyspepsia 1.3% - 5.2% 1.2% - 11.1% x x x x x
Diarrhoea Diarrhoea 1.3% - 9% 0% - 9.5% x x x x x x x x x
Dysmenorrhoea Dysmenorrhoea 0% - 7.6% 0% - 6.3% x x x x
Vomiting Vomiting very rare — 0.602% - 4.8% 0% - 3.4% x x x x x x x x x x x
Asthenia Fatigue 0.6% - 4.8% 0% - 3.4% x x x x x x x x x
Fatigue Fatigue 0.6% - 4.8% 0% - 3.4% x x x x x x x x x
Insomnia Insomnia 1.2% - 1.84% x
Abdominal pain upper Abdominal pain upper 0.613% - 2.41% x
Abdominal pain Abdominal pain 0% - 7.9% 0% - 7.9% x x x x x x x x x
Gastrointestinal pain Abdominal pain 0% - 7.9% 0% - 7.9% x x x x x x x x x
Dizziness Dizziness very rare — 0% - 2.41% 0% - 3.1% x x x x x x x x x x x
Nasopharyngitis Nasopharyngitis 0% - 2.64% 0.787% x x x
Blood creatine phosphokinase increased Creatine phosphokinase increased 0.7% - 2% x x
Hyperbilirubinaemia Hyperbilirubinaemia 1.3% 1.6% x x x
Leukopenia Leukopenia 1.3% 0% - 0.9% x x x x x x
Laryngeal pain Pharyngolaryngeal pain 0.602% - 1.84% x
Pruritus Pruritus very rare — 0% - 3.7% 0% - 2.7% x x x x x x x x x x x
Somnolence Somnolence very rare — 0.6% - 1.2% 1.1% - 2.7% x x x x x x x x x x x
Body temperature increased Body temperature increased 1.1% 0% x x x
Flatulence Flatulence 0.2% - 4.8% 0% - 1.6% x x x x x x
Constipation Constipation 1% 0% x x x
Hyperhidrosis Sweating increased 1% 0% x x x
Abdominal discomfort Upset stomach 0.602% - 1.23% x
Anxiety Anxiety 0% - 1.23% x
Palpitations Palpitations 0% - 1.23% x x
Fungal infection Fungal infection 0% - 1.2% x
Migraine Migraine 0.2% - 3.1% 0% - 0.7% x x x
Gamma-glutamyltransferase increased Gamma-glutamyltransferase increased 0.6% 1.4% x x x
Chills Rigors 0.6% 1.4% x x x
Angioedema Angioedema postmarketing, uncommon x x x x
Decreased appetite Anorexia 0.5% 1.4% x x x
Herpes zoster Herpes zoster 0.5% 1.4% x x x
Dry mouth Dry mouth 0% - 1.23% 1.2% x x x x
Periorbital oedema Periorbital oedema postmarketing, uncommon x x x x
Eyelid oedema Eyelid oedema postmarketing, uncommon x x x x
Pharyngeal oedema Pharyngeal oedema postmarketing, uncommon x x x x
Face oedema Face oedema postmarketing, uncommon x x x x
Hepatic enzyme increased Hepatic enzyme increased 0.2% 1.4% x x x
Anaemia Anaemia 0.1% 0% x x x
Mental disorder Mental disorder postmarketing x x x x x x x x
Confusional state Confusional state postmarketing — uncommon x x x x x x x x x x x
Feeling abnormal Confusional state postmarketing — uncommon x x x x x x x x x x x
Delirium Delirium postmarketing x x x x x x
Toxic epidermal necrolysis Toxic epidermal necrolysis postmarketing x x x x x x x x x x x
Erythema multiforme Erythema multiforme postmarketing x x x x x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x x
Gastrointestinal disorder Gastrointestinal disorder postmarketing x x x x x
Hallucination Hallucination very rare — rare x x x x x x x x x x x
Jaundice cholestatic Jaundice cholestatic very rare — rare x x x x x x x x
Musculoskeletal disorder Musculoskeletal disorder postmarketing x x x
Nervous system disorder Nervous system disorder postmarketing x x x x x x x x
Stevens-Johnson syndrome Stevens-Johnson syndrome postmarketing x x x x x x x x x x x
Thrombocytopenia Thrombocytopenia very rare — rare x x x x x x x x x x x
Urticaria Urticaria very rare — uncommon x x x x x x x x x x x
Liver function test abnormal Liver function test abnormal very rare — common x x x x x x x x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x x x x
Disorientation Disorientation postmarketing x x x x x x
Hepatobiliary disease Hepatobiliary disease postmarketing x x x x x x x x
Arthralgia Arthralgia very rare, postmarketing x x x
Musculoskeletal discomfort Arthralgia very rare, postmarketing x x x
Myalgia very rare, postmarketing x x x
Dermatitis Rash very rare — 0% - 3.3% 0% - 1.6% x x x x x x x x x
Rash Rash very rare — 0% - 3.3% 0% - 1.6% x x x x x x x x x
Myalgia Myalgia very rare, postmarketing x x x
Cardiac disorder Cardiac disorder x
Jaundice Jaundice x x x
Renal failure acute Renal failure acute x x x
Paraesthesia Paraesthesia 0% - 2.6% 0% x x x
Tinnitus Tinnitus 0% 1.4% x x x
Lipase increased Lipase increased x x x
Leukocytoclastic vasculitis Leukocytoclastic vasculitis x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

FAMCICLOVIR / APO-FAMCICLOVIR

Side effects:36
Source:Health Canada

FAMCICLOVIR / SANDOZ FAMCICLOVIR

Side effects:36
Source:Health Canada

FAMCICLOVIR / FAMVIR TABLETS 500MG

Side effects:37
Source:Health Canada

FAMCICLOVIR

Side effects:34
Source:FDA Structured Product Label

FAMCICLOVIR

Side effects:34
Source:FDA Structured Product Label

FAMCICLOVIR

Side effects:34
Source:FDA Structured Product Label

FAMVIR ONCE / Famvir Once, Tablet

Side effects:27
Source:Medsafe

famciclovir / FAMVIR

Side effects:37
Source:medicines.org.au

Famciclovir / EZOVIR

Side effects:35
Source:medicines.org.au

Famciclovir / FAMCICLOVIR TABLETS

Side effects:49
Source:medicines.org.au

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label